Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Ophthalmological assessment of children with neurofibromatosis type 1.

Alpfidan I, Sakarya Y, Goktas S, Ozcimen M, Sakarya R.

Eur J Pediatr. 2014 Feb;173(2):259. doi: 10.1007/s00431-013-2145-x. Epub 2013 Aug 22. No abstract available.

PMID:
23975410
2.

Reply to correspondence letter 'Ophthalmological assessment of children with neurofibromatosis type 1'.

Cassiman C.

Eur J Pediatr. 2014 Feb;173(2):261. doi: 10.1007/s00431-013-2146-9. Epub 2013 Aug 24. No abstract available.

PMID:
23975411
3.

Ophthalmological assessment of children with neurofibromatosis type 1.

Cassiman C, Legius E, Spileers W, Casteels I.

Eur J Pediatr. 2013 Oct;172(10):1327-33. doi: 10.1007/s00431-013-2035-2. Epub 2013 May 25. Review.

PMID:
23708214
4.

[Pathogenesis and the most frequent symptoms of neurofibromatosis type 1].

Czajkowski G, Kałuzny J, Jatczak-Gaca A, Wysocki M.

Klin Oczna. 2009;111(10-12):378-83. Review. Polish.

PMID:
20169901
5.

Concomitant meningioma and glioma within the same optic nerve in neurofibromatosis type 1.

Büyükkapu-Bay S, Akça A, Karadoğan M, Çorapçioğlu F, Anik Y.

J Child Neurol. 2014 Mar;29(3):385-8. doi: 10.1177/0883073812475157. Epub 2013 Feb 17.

PMID:
23420652
6.

Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials.

Chang BC, Mirabella G, Yagev R, Banh M, Mezer E, Parkin PC, Westall CA, Buncic JR.

Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2895-902.

PMID:
17525226
7.

[Long-term outcome of gliomas of the visual pathway in type 1 neurofibromatosis].

Schröder S, Baumann-Schröder U, Hazim W, Haase W, Mautner VF.

Klin Monbl Augenheilkd. 1999 Dec;215(6):349-54. German.

PMID:
10637799
8.

[Usefulness of systematic brain magnetic resonance imaging in children with neurofibromatosis type 1].

Blanchard G, Pinson S, Rousselle C, Lorthois S, Combemale P, Bernard M, Lion Francois L.

Arch Pediatr. 2009 Dec;16(12):1527-32. doi: 10.1016/j.arcped.2009.09.014. Epub 2009 Oct 27. French.

PMID:
19864117
9.

Optic pathway gliomas: a review.

Fried I, Tabori U, Tihan T, Reginald A, Bouffet E.

CNS Oncol. 2013 Mar;2(2):143-59. doi: 10.2217/cns.12.47. Review.

PMID:
25057976
10.

Utility of optic pathway glioma screening in young children with neurofibromatosis type I: questions generated by a clinical audit.

Pilling RF, Lloyd IC, Huson S.

Eye (Lond). 2010 Oct;24(10):1603-5. doi: 10.1038/eye.2010.99. Epub 2010 Aug 6.

PMID:
20689568
11.

Late-onset optic pathway tumors in children with neurofibromatosis 1.

Listernick R, Ferner RE, Piersall L, Sharif S, Gutmann DH, Charrow J.

Neurology. 2004 Nov 23;63(10):1944-6. Review.

PMID:
15557519
12.

Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging.

Balcer LJ, Liu GT, Heller G, Bilaniuk L, Volpe NJ, Galetta SL, Molloy PT, Phillips PC, Janss AJ, Vaughn S, Maguire MG.

Am J Ophthalmol. 2001 Apr;131(4):442-5.

PMID:
11292406
13.

Screening children with NF1 for optic pathway glioma--No.

Pilling RF, Taylor RH.

Eye (Lond). 2010 Sep;24(9):1432-4. doi: 10.1038/eye.2010.94. Epub 2010 Jun 25. No abstract available. Erratum in: Eye (Lond). 2010 Nov;24(11):1737.

PMID:
20577270
14.

Screening children with NF1 for optic pathway glioma--Yes.

Simmons I, Gogi D.

Eye (Lond). 2010 Sep;24(9):1429-31. doi: 10.1038/eye.2010.93. Epub 2010 Jun 25. No abstract available.

PMID:
20577275
15.

Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.

Segal L, Darvish-Zargar M, Dilenge ME, Ortenberg J, Polomeno RC.

J AAPOS. 2010 Apr;14(2):155-8. doi: 10.1016/j.jaapos.2009.11.020.

PMID:
20451859
16.

The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1.

Prada CE, Hufnagel RB, Hummel TR, Lovell AM, Hopkin RJ, Saal HM, Schorry EK.

J Pediatr. 2015 Oct;167(4):851-856.e1. doi: 10.1016/j.jpeds.2015.07.001. Epub 2015 Jul 29.

PMID:
26233602
17.
18.

Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.

Listernick R, Ferner RE, Liu GT, Gutmann DH.

Ann Neurol. 2007 Mar;61(3):189-98. Review.

PMID:
17387725
19.

Feasibility and comparison of visual acuity testing methods in children with neurofibromatosis type 1 and/or optic pathway gliomas.

Avery RA, Bouffet E, Packer RJ, Reginald A.

Invest Ophthalmol Vis Sci. 2013 Feb 5;54(2):1034-8. doi: 10.1167/iovs.12-11385.

PMID:
23329671
20.

Type I neurofibromatosis: a geno-oculo-dermatologic update.

Schnur RE.

Curr Opin Ophthalmol. 2012 Sep;23(5):364-72. doi: 10.1097/ICU.0b013e3283570127. Review.

PMID:
22871881
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk